Medical Capital Advisors congratulates the Musculoskeletal Transplant Foundation (MTF), the world’s largest tissue bank, on its new agreement with CONMED Corporation. The organizations will join forces and CONMED Linvatec will serve as the exclusive world-wide marketing representative for MTF’s sports medicine allograft tissues. CONMED Linvatec will also assume responsibility for the global distribution of MTF’s Cascade Platelet-Rich Plasma (PRP) product, which uses a patient’s own blood components to aid in the healing process.
This long term relationship will expand global reach and open new channels for MTF’s distribution, helping them to increase access to tissue donations when and where they are most needed. MTF will continue its commitment to excellence in education, research, recovery and care for recipients, donors and their families.
MedCap Advisors provides merger advisory services, strategic consulting, and valuation services to medical technology and healthcare companies around the globe. MedCap also collaborates with major universities by investing in and founding new medical technology companies through its fund, GreyMatter Health Ventures. We invite executives and entrepreneurs to visit with us at the American Academy of Orthopedic Surgeons in San Francisco between February 7–11, 2012.